A combination of
photothermal therapy (PTT) and
chemotherapy is an emerging therapeutic strategy with promising clinical prospects in
cancer treatment. Despite the huge progress achieved in the past years, a number of obstacles still hamper the therapeutic efficacy of this synergistic modality such as uneven heat distribution, lack of targetability of anti-
cancer agents and dosage-related side effects. Thus, developing a nanoplatform for targeted drug delivery against
cancer is of great necessity. Herein, a
lipid-
polymer hybrid nanosystem (LP/ID) based on
polyethyleneimine (PEI)-
lecithin-
polyethylene glycol (PEG) was fabricated to co-load
indocyanine green (ICG) and dichloroacetate (DCA) for combined photothermal/
chemotherapy. DCA and ICG were linked to the PEI backbone to form a dense hydrophobic core through
amide bonds and electrostatic interactions, which increased the payload of DCA and ICG as well as achieved
enzyme-responsive drug release because of the overexpressed
amidase in
tumor cells.
Lecithin and
DSPE-PEG2000 self-assembled around the hydrophobic complexes to obtain prolonged blood circulation and attenuated systemic toxicity of the hybrid nanosystem. The prepared LP/ID exhibited favourable stability in a physiological environment, good
tumor imaging properties, and satisfactory photothermal/chemotherapeutic performance. Moreover, LP/ID could also enhance the cellular uptake and
tumor retention capacity in comparison with free drug administration. Notably, by co-loading two therapeutic agents with different anti-
cancer mechanisms, an obvious inhibitory effect on
tumor growth was observed with negligible damage to normal tissues and organs because of the synergistic photothermal/
chemotherapy effect, indicating the great potential of LP/ID as a robust nanoplatform for
cancer treatment.